Comparative In Vitro Antimicrobial Activities of the Newly Synthesized Quinolone Hsr-903, Sitafloxacin (Du-6859a) , Gatifloxacin (Am-1155) , and Levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium Complex

Tomioka, H.; Sato, K.; Akaki, T.; Kajitani, H.; Kawahara, S.; Sakatani, M.

Antimicrobial Agents and Chemotherapy 43(12): 3001-3004

1999


ISSN/ISBN: 0066-4804
DOI: 10.1128/aac.43.12.3001
Accession: 067646774

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 0-6 h
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Abstract
We compared the in vitro antimycobacterial activity of a new fluoroquinolone, HSR-903, with strong activity against gram-positive cocci with those of levofloxacin (LVFX), sitafloxacin (STFX), and gatifloxacin (GFLX). The MICs of the quinolones for Mycobacterium tuberculosis and Mycobacterium avium complex were in the order STFX approximately GFLX < LVFX <== HSR-903 and STFX <== GFLX <== HSR-903 <== LVFX, respectively. HSR-903 effectively eliminated intramacrophagial M. tuberculosis, as did LVFX, and exhibited bacteriostatic effects against M. tuberculosis replicating in type II alveolar cells.